This is important as
the poor immunogenicity of these cells could be exploited for transplanting across MHC barriers with minimal conditioning of the host.
Vaccine studies in infants < 6 mo with novel vaccine candidates have generally demonstrated
poor immunogenicity (90).
Not exact matches
Synthetic peptides corresponding to microbial epitopes stimulate T cell immunity but their
immunogenicity is
poor and their half - lives are short.